HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

vandetanib (ZD6474)

a VEGF receptor tyrosine kinase inhibitor
Also Known As:
ZD6474; Caprelsa; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; ZD 6474; ZD-64; ZD-6474; Zactima
Networked: 574 relevant articles (74 outcomes, 183 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ryan, Anderson J: 23 articles (01/2014 - 12/2002)
2. Heymach, John V: 15 articles (04/2016 - 07/2006)
3. Ciardiello, Fortunato: 13 articles (05/2014 - 12/2002)
4. Schlumberger, Martin: 12 articles (11/2021 - 02/2010)
5. Leboulleux, Sophie: 10 articles (11/2021 - 09/2011)
6. Herbst, Roy S: 10 articles (03/2015 - 02/2007)
7. Tortora, Giampaolo: 10 articles (02/2011 - 12/2002)
8. Ryan, Anderson: 10 articles (11/2009 - 01/2004)
9. Elisei, Rossella: 8 articles (01/2021 - 01/2012)
10. Subbiah, Vivek: 8 articles (01/2021 - 02/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. medullary Thyroid cancer
4. Thyroid Neoplasms (Thyroid Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. vandetanib (ZD6474)
2. ErbB Receptors (EGF Receptor)
3. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
4. Tyrosine Kinase Inhibitors
5. Docetaxel (Taxotere)
6. cabozantinib
7. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
8. Sorafenib (BAY 43-9006)
9. Erlotinib Hydrochloride (CP 358,774)
10. Gemcitabine

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiotherapy
4. Aftercare (After-Treatment)
5. Castration